4/5BioCrude Technologies USA, Inc.: Auditor change

Market data

n/a: no ticker symbol on the filing.

Insider trading around this filing

90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-11-07 to 2026-03-07. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"On February 3, 2026, the Company engaged Bodwell Vasek Wells DeSimone LLP's ("BVWD"), situated at 8117 Preston Road, Suite 460, Dallas, Texas 75225 (Ph: Tel: 903- 624.9078;"

Quoted from the filing. Source

What this means

The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.

Type: changed
Disagreements reported: no
New auditor: Bodwell Vasek Wells DeSimone LLP

Why this score: also within 90 days: Going-concern doubt